Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
02/13/2008 | CN101124318A Novel strain conferring anti-disease properties to host and bacterial cell composition |
02/13/2008 | CN101124237A Surface proteins of streptococcus pyogenes |
02/13/2008 | CN101124195A Purification process |
02/13/2008 | CN101124014A Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
02/13/2008 | CN101123979A Treatment of hepatitis c in the asian population with interferon-beta |
02/13/2008 | CN101121937A Colibacillus gene engineering bacterin K88-K99-LT for firstborn piglet diarrhea and construction method thereof |
02/13/2008 | CN101121936A Colibacillus gene engineering bacterin 987P-ST-F41 for firstborn piglet diarrhea and construction method thereof |
02/13/2008 | CN101121922A Preparation method for wine brewing yeast cell culture secretion and use for the same in resisting DNA virus and promoting hepatocyte growth |
02/13/2008 | CN101121701A Five-membered rings 3-position single-substituted benzosultam derivatives and preparation method thereof |
02/13/2008 | CN101121698A Diarylmiazines derivatives, preparation method and use thereof |
02/13/2008 | CN101121023A Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
02/13/2008 | CN101121018A Application of recombination FN polypeptide in preparing medicine for treating severe infectious diseases such as septicemia |
02/13/2008 | CN101121015A Traditional Chinese medicine for treating influenza and preparation method thereof |
02/13/2008 | CN101120986A Body-clearing itching-relieving liquid |
02/13/2008 | CN101120967A Medicine for treating hepatosis |
02/13/2008 | CN101120947A Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
02/13/2008 | CN101120927A Wet granulation technology for cefuroxime axetil tablets |
02/13/2008 | CN101120926A Freezing-dried preparation containing voriconazole and its preparation method |
02/13/2008 | CN101120911A Ftibamzone chrisma with propanediol as co-solvent |
02/13/2008 | CN101120758A Liquid acidifier and preparation method |
02/13/2008 | CN100368438C Anti-hepatitis B virus fusion protein and its coding gene and application |
02/13/2008 | CN100368428C 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
02/13/2008 | CN100368419C Industrial production process of palmitate of clindamycin hydrochloride |
02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
02/13/2008 | CN100368403C Anti anaerbic bacterial compound |
02/13/2008 | CN100367999C Herbal Chinese medicine for treating phthisis |
02/13/2008 | CN100367990C Drug comprising orazamide |
02/13/2008 | CN100367988C Chinese medicine for treating dermatomycosis and its preparing process |
02/13/2008 | CN100367986C Cooperative drug comprising biphenyldicarboxylate |
02/13/2008 | CN100367984C Virosis-treating medicine for prawn and its preparation process |
02/13/2008 | CN100367980C Cooperative compositions comprising biphenyldicarboxylate |
02/13/2008 | CN100367979C Freeze dried injection with heat-clearing, antibiosis and antiviral function and preparation method thereof |
02/13/2008 | CN100367978C Synergistic medicinal composition |
02/13/2008 | CN100367971C Baicalin dropping pill and its preparing method |
02/13/2008 | CN100367968C Yinhuang (honeysuckle and Rdix astragali) soft capsule pharmaceutics and preparation process thereof |
02/13/2008 | CN100367957C Abiduoer and its salts prepns. for vena administration, and its preparing method |
02/13/2008 | CN100367954C Andrographolide soft capsule formulation and preparation method |
02/13/2008 | CN100367948C Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
02/13/2008 | CN100367936C Oral drop pill in use for clearing sway heat and toxic material, relieving inflammation and dysentery, and preparation method |
02/13/2008 | CN100367935C Oral drop pills in use for treating diseases of bacterial infection and preparation method |
02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
02/12/2008 | US7329795 Screening substances promoting or suppressing response to mycobacterial lipoproteins/lipopeptides by contacting peritoneal macrophages isolated from transgenic toll-like receptor 1 inactivated mouse with the substance and comparing the response to that using macrophages from a control mouse |
02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
02/12/2008 | US7329761 Substituted imides |
02/12/2008 | US7329760 CC-1065 analog synthesis |
02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
02/12/2008 | US7329731 Soluble T cell receptor |
02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
02/12/2008 | US7329513 High level constitutive production of anthrax protective antigen |
02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
02/12/2008 | US7329417 Advantage in using the silver ion as antiseptic agent is the general lack of formation of bacterial tolerance |
02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
02/12/2008 | US7329408 Eliciting HCV-specific antibodies |
02/12/2008 | CA2468033C A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent |
02/12/2008 | CA2445306C Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
02/12/2008 | CA2416823C Antimycotic nail varnish composition |
02/12/2008 | CA2387018C Chemokine receptor |
02/12/2008 | CA2374003C Improved cellular uptake of bioactive agents |
02/12/2008 | CA2346132C Antibacterial agents and process for producing the same |
02/12/2008 | CA2332922C Enteric coated pharmaceutical composition and method of manufacturing |
02/12/2008 | CA2303447C Cationic polymers as toxin-binding agents |
02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
02/12/2008 | CA2275259C Formulations of recombinant papillomavirus vaccines |
02/12/2008 | CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced |
02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
02/12/2008 | CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160 |
02/12/2008 | CA2116500C Canine coronavirus vaccine from feline enteric coronavirus |
02/12/2008 | CA2104699C Sustained release drug delivery devices |
02/07/2008 | WO2008016738A2 Antibacterial agents and related screening methods using small molecule macroarrays |
02/07/2008 | WO2008016655A2 Method of administration of an hiv immunogenic composition |
02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
02/07/2008 | WO2008016108A1 Agent for preventing infection |
02/07/2008 | WO2008016078A1 Method of proliferating lak cell |
02/07/2008 | WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR |
02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
02/07/2008 | WO2008015309A1 Dendrimeric peptide construct for the prevention of foot-and-mouth disease in animals |
02/07/2008 | WO2008014824A1 Antiviral use of cationic surfactant |
02/07/2008 | WO2007146550A3 Alkene piperidine derivatives as antiviral agents |
02/07/2008 | WO2007136300A3 Substituted indoles and a method for the production and use thereof |
02/07/2008 | WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations |
02/07/2008 | WO2007082864A3 Use of chavicol as an antiseptic |
02/07/2008 | WO2006130627A3 Methods for treating hepatitis c |
02/07/2008 | US20080033170 Novel compounds |
02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
02/07/2008 | US20080033038 Compositions of polyphenols and methods of use |
02/07/2008 | US20080033021 Wash composition for the handling of contact lenses |
02/07/2008 | US20080033012 Enzyme inhibitors |
02/07/2008 | US20080033008 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof |
02/07/2008 | US20080033003 Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents |
02/07/2008 | US20080032999 viricides for treating a hepatitis C virus infection |
02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
02/07/2008 | US20080032969 Novel compounds |
02/07/2008 | US20080032962 Stabilized Freeze-Dried Formulation for Cephalosporin Derivatives |